QIAGEN IPA
Somatic variants investigation in critical regulatory pathways
264 views
This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and Human Somatic Mutation Database (HSMD) to identify key somatic variants associated with regulatory genes in ‘omic data and study the genomic characteristics of both target and disease to better understand the clinical relevance. Identifying and studying the genomic characteristics of drug targets and important genes are of great interest to many researchers as it can offer new insights into improving drug discovery and precision medicine. In this 90-minute training, the Human Somatic Mutation Database (HSMD) will be introduced for genomic investigation. HSMD is a web-based database containing data for hundreds of thousands of variants within the context of solid tumors and hematological malignancies. Specifically, HSMD provides gene-level, alteration-level, and disease-level information including clinically observed gene and variant frequencies across cancer types.
Attendees will learn how to:
· Use IPA to identify key regulators within a dataset of interest
· Use HSMD to investigate variants for target genes and cancer type of interest
· Synthesize key findings from drug labels, clinical trials, and PubMed articles for specific alterations and cancer types
Related videos
QIAGEN IPA
Analyze, compare and contextualize your biological data with QIAGEN IPA
Discover why QIAGEN Ingenuity Pathway Analysis (IPA) is more than just...
QIAGEN IPA
Interpreting your comparison analyses results in IPA
Learn how to view and interpret your comparison analyses results in IPA and...
QIAGEN IPA
Interpreting the Results of Your Phosphoproteomics Analysis in IPA
Learn how to view and interpret your Phosphoproteomics Analysis results in...
QIAGEN IPA
New user training: QIAGEN Ingenuity Pathway Analysis (IPA)
New user training: Large dataset analysis and knowledge base queries using...